נולוג'יקס 250 מ"ג

Krajina: Izrael

Jazyk: hebrejčina

Zdroj: Ministry of Health

Aktívna zložka:

BELATACEPT 25 MG/ML

Dostupné z:

BRISTOL-MYERS SQUIBB (ISRAEL) LIMITED

ATC kód:

L04AA28

Forma lieku:

POWDER FOR CONCENTRATE FOR INFUSION

Spôsob podávania:

I.V

Výrobca:

BRISTOL-MYERS SQUIBB S.R.L, ITALY

Terapeutické skupiny:

BELATACEPT

Terapeutické indikácie:

Nulojix, in combination with corticosteroids and mycophenolic acid (MPA), is indicated for prophylaxis of graft rejection in adults receiving a renal transplant. It is recommended to add an interleukin (IL)-2 receptor antagonist for induction therapy to this belatacept-based regimen

Dátum Autorizácia:

2012-08-01